Redox biology and therapeutics in chronic lung disease is a research paper published in Redox Biology (2020). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: P01 HL114470
National Institutes of Health
Grant: R01 HL139617
National Institutes of Health
Grant: R01 AG046210
U.S. Department of Veterans Affairs
Grant: I01BX003056
National Institutes of Health
Grant: 5R01HL139617-04
AMPK in the Development and Resolution of Lung Fibrosis
National Institutes of Health
Grant: 5I01BX003056-08
Sirtuins in Lung Aging and Fibrosis
National Institutes of Health
Grant: 7P01HL114470-09
Therapeutic Targeting of the Myofibroblast in Fibrotic Lung Disease
National Institutes of Health
Grant: 5R01AG046210-03
Myofibroblast Senescence in Pulmonary Fibrosis
FWCI
0.22
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals